| Literature DB >> 34607184 |
Alexander J Scott1, Thomas L Webb2, Marrissa Martyn-St James3, Georgina Rowse4, Scott Weich3.
Abstract
The extent to which sleep is causally related to mental health is unclear. One way to test the causal link is to evaluate the extent to which interventions that improve sleep quality also improve mental health. We conducted a meta-analysis of randomised controlled trials that reported the effects of an intervention that improved sleep on composite mental health, as well as on seven specific mental health difficulties. 65 trials comprising 72 interventions and N = 8608 participants were included. Improving sleep led to a significant medium-sized effect on composite mental health (g+ = -0.53), depression (g+ = -0.63), anxiety (g+ = -0.51), and rumination (g+ = -0.49), as well as significant small-to-medium sized effects on stress (g+ = -0.42), and finally small significant effects on positive psychosis symptoms (g+ = -0.26). We also found a dose response relationship, in that greater improvements in sleep quality led to greater improvements in mental health. Our findings suggest that sleep is causally related to the experience of mental health difficulties. Future research might consider how interventions that improve sleep could be incorporated into mental health services, as well as the mechanisms of action that explain how sleep exerts an effect on mental health.Entities:
Keywords: Anxiety; CBTi; Causal inference; Depression; Insomnia; Mental health; Meta-analysis; Psychosis; Sleep; Stress
Mesh:
Year: 2021 PMID: 34607184 PMCID: PMC8651630 DOI: 10.1016/j.smrv.2021.101556
Source DB: PubMed Journal: Sleep Med Rev ISSN: 1087-0792 Impact factor: 11.609
Search terms used to identify RCT's that examined the effect of improving sleep on mental health.
| HSSS for RCTs | Sleep terms | Mental health terms |
|---|---|---|
| Randomi$ed controlled trial | Sleep∗ | “Psychological health” |
| Controlled clinical trial | “Circadian rhythm” | “Mental” |
| Randomi$ed | Insomnia | Psychiat∗ |
| Placebo | Hypersomnia | Affect∗ |
| Drug therapy | Parasomnia | Depress∗ |
| Randomly | Narcolepsy | Mood |
| Trial | Apn$ea | Stress |
| Groups | Nightmare∗ | Anxi∗ |
| “Restless leg∗ syndrome” | Phobi∗ | |
| “Obsessive compulsive disorder” | ||
| OCD | ||
| PTSD | ||
| “Post-traumatic stress disorder” | ||
| Psychos∗ | ||
| Psychotic | ||
| Schiz∗ | ||
| Bipolar | ||
| Hallucination∗ | ||
| Delusion∗ | ||
| “Eating disturbance∗” | ||
| Anorexia | ||
| Bulimia | ||
| “Binge eating” |
Notes: HSSS for RCTs = highly sensitive search strategy for randomised controlled trials, OCD = obsessive compulsive disorder, PTSD = post-traumatic stress disorder.
Summary of studies included in the review.
| Author (year) | Intervention | Control | Outcome | Measure | |||
|---|---|---|---|---|---|---|---|
| Alessi et al. (2016) [ | CBTi | Sleep education | Depression | PHQ-9 | 89 | 51 | 0.20 |
| Ashworth et al. (2015) [ | CBTi | CBTi (self-help) | Anxiety | DASS-A | 18 | 18 | −1.41∗∗∗ |
| Depression | BDI | 18 | 18 | −2.31∗∗∗ | |||
| Behrendt et al. (2020) [ | CBTi | WLC | Depression | CES-D | 46 | 80 | −0.52∗∗ |
| Rumination | PSWQ | 46 | 80 | −0.45∗ | |||
| Bergdahl et al. (2016) [ | CBTi | Acupuncture | Anxiety | HADS-A | 23 | 22 | 0.03 |
| Depression | HADS-D | 23 | 22 | 0.06 | |||
| Blom et al. (2017) [ | CBTi | CBT for depression | Depression | MADRS | 20 | 17 | −0.31 |
| Cape et al. (2016) [ | CBTi | TaU | Anxiety | GAD-7 | 91 | 99 | −0.11 |
| Depression | PHQ-9 | 92 | 100 | −0.20 | |||
| Casault et al. (2015) [ | CBTi | WLC | Anxiety | HADS-A | 17 | 18 | −0.39 |
| Depression | HADS-D | 17 | 18 | −0.11 | |||
| Chang et al. (2016) [ | Herbal tea | WLC | Depression | EPDS | 35 | 37 | −0.52∗ |
| Chang et al. (2016) [ | Sleep education + relaxation | WLC | Anxiety | HADS-A | 43 | 41 | −0.68∗∗ |
| Depression | HADS-D | 43 | 41 | −0.52∗ | |||
| Chao et al. (2021) [ | CBTi | WLC | Depression | HADS-D | 32 | 39 | −0.67∗∗ |
| Anxiety | HADS-A | 32 | 39 | −0.60∗ | |||
| Chen et al. (2009) [ | Yoga | TaU | Depression | TDS | 62 | 66 | −0.60∗∗∗ |
| Chen et al. (2019) [ | Acupuncture | Sham acupuncture | Mood/affect | K-10 | 31 | 31 | −0.50 |
| Cheng et al. (2019) [ | CBTi | Sleep education | Depression | QIDS | 358 | 300 | −0.45∗∗∗ |
| Christensen et al. (2016) [ | CBTi | Health education | Anxiety | GAD-7 | 224 | 280 | −0.34∗∗∗ |
| Depression | PHQ-9 | 224 | 280 | −0.53∗∗∗ | |||
| Chung et al. (2018) [ | Acupuncture | WLC | Anxiety | HADS-A | 71 | 32 | −0.37 |
| Depression | HADS-D | 71 | 32 | −0.46∗ | |||
| Currie et al. (2000) [ | CBTi | WLC | Depression | BDI | 32 | 28 | −0.31 |
| Edinger et al. (2005)a [ | CBTi | TaU | Mood/affect | POMS | 6 | 7 | −1.27 |
| Edinger et al. (2005)b [ | Sleep hygiene | TaU | Mood/affect | POMS | 7 | 7 | −1.00 |
| Espie et al. (2008) [ | CBTi | Sleep hygiene | Anxiety | HADS-A | 67 | 39 | −0.52∗ |
| Depression | HADS-D | 67 | 39 | −0.59∗∗ | |||
| Espie et al. (2014) [ | CBTi | TaU | Anxiety | DASS-A | 40 | 47 | −0.79∗∗∗ |
| Depression | DASS-D | 40 | 47 | −0.94∗∗∗ | |||
| Stress | DASS-S | 40 | 47 | −0.93∗∗∗ | |||
| Espie et al. (2019) [ | CBTi | WLC | Anxiety | GAD-7 | 411 | 495 | −0.31∗∗∗ |
| Depression | PHQ-9 | 411 | 495 | −0.39∗∗∗ | |||
| Falloon et al. (2015) [ | Sleep restriction | Sleep hygiene | Anxiety | GAD-7 | 43 | 50 | −0.50∗ |
| Depression | PHQ-9 | 43 | 50 | −0.27 | |||
| Felder et al. (2020) [ | CBTi | TaU | Depression | EPDS | 88 | 91 | −0.40∗∗ |
| Anxiety | GAD-7 | 88 | 90 | −0.37∗ | |||
| Freeman et al. (2015) [ | CBTi | TaU | Delusions | PSYRATS | 23 | 25 | −0.24 |
| Hallucinations | PSYRATS | 23 | 25 | −0.23 | |||
| Paranoia | GPTS | 20 | 25 | −0.28 | |||
| Psychosis | PANSS tot | 21 | 24 | −0.07 | |||
| Freeman et al. (2017) [ | CBTi | TaU | Anxiety | GAD-7 | 603 | 971 | −0.26∗∗∗ |
| Depression | PHQ-9 | 603 | 971 | −0.35∗∗∗ | |||
| Hallucinations | SPEQ | 603 | 971 | −0.27∗∗∗ | |||
| Paranoia | GPTS | 603 | 971 | −0.27∗∗∗ | |||
| Garland et al. (2014) [ | CBTi | Mindfulness | Mood/affect | POMS | 40 | 32 | −0.19 |
| Stress | C–SOSI | 40 | 32 | −0.26 | |||
| Garland et al. (2019) [ | CBTi | Acupuncture | Anxiety | HADS-A | 73 | 75 | 0.02 |
| Depression | HADS-D | 73 | 75 | −0.09 | |||
| Germain et al. (2012) [ | CBTi + IRT | Prazosin placebo | Anxiety | BAI | 12 | 12 | −0.28 |
| Depression | BDI | 12 | 12 | −0.36 | |||
| PTSD | PCL | 12 | 12 | −0.46 | |||
| Glozier et al. (2019) [ | CBTi | Sleep education | Depression | CES-D | 31 | 28 | −0.03 |
| Ham et al. (2020) [ | CBTi | Sleep hygiene | Depression | CES-D | 24 | 20 | −0.56 |
| Ho et al. (2014)a [ | CBTi + telephone support | WLC | Anxiety | HADS-A | 49 | 33 | −0.21 |
| Depression | HADS-D | 49 | 33 | −0.13 | |||
| Ho et al. (2014)b [ | CBTi | WLC | Anxiety | HADS-A | 45 | 33 | −0.19 |
| Depression | HADS-D | 45 | 33 | −0.16 | |||
| Irwin et al. (2014)a [ | CBTi | WLC | Depression | IDS-C | 46 | 11 | −0.63 |
| Irwin et al. (2014)b [ | Tai Chi | WLC | Depression | IDS-C | 39 | 12 | −0.22 |
| Jansson-Frojmark et al. (2012) [ | CBTi | WLC | Anxiety | HADS-A | 15 | 15 | −1.19∗∗ |
| Depression | HADS-D | 15 | 15 | −1.12∗∗ | |||
| Jernelov et al. (2012)a [ | CBTi + telephone support | WLC | Mood/affect | CORE-OM | 44 | 22 | −0.50 |
| Stress | PSS | 44 | 22 | −0.64∗ | |||
| Jernelov et al. (2012)b [ | CBTi | WLC | Mood/affect | CORE-OM | 45 | 22 | −0.39 |
| Stress | PSS | 45 | 22 | −0.30 | |||
| Jungquist et al. (2012) [ | CBTi | Self-monitoring | Depression | BDI | 14 | 4 | −2.44∗∗∗ |
| Kaldo, V et al. (2015) [ | CBTi | Mindfulness + sleep hygiene + relaxation | Stress | PSS | 54 | 53 | 0.00 |
| Kalmbach et al. (2019)a [ | CBTi | Sleep hygiene | Depression | BDI-II | 42 | 20 | −0.45 |
| Rumination | ERRI | 42 | 20 | −0.17 | |||
| Rumination | PSWQ | 42 | 20 | −0.38 | |||
| Kalmbach et al. (2019)b [ | CBTi | Sleep hygiene | Depression | BDI-II | 34 | 20 | −0.51 |
| ERRI | 34 | 20 | −0.08 | ||||
| PSWQ | 34 | 20 | −0.53 | ||||
| Katofsky et al. (2012) [ | CBTi + sleep medication | Sleep medication | Depression | BDI | 41 | 39 | −0.11 |
| Kyle et al. (2020) [ | CBTi | WLC | Depression | PHQ-9 | 136 | 166 | −0.53∗∗∗ |
| Anxiety | GAD-7 | 136 | 166 | −0.33∗∗ | |||
| Lancee et al. (2012)a [ | CBTi (digital) | WLC | Anxiety | HADS-A | 109 | 92 | −0.17 |
| Depression | CES-D | 109 | 42 | −0.23 | |||
| Lancee et al. (2012)b [ | CBTi (booklet) | WLC | Anxiety | HADS-A | 126 | 91 | −0.02 |
| Depression | CES-D | 126 | 41 | −0.03 | |||
| Lancee et al. (2013) [ | CBTi | CBTi (self-help) | Anxiety | HADS-A | 102 | 95 | −0.16 |
| Depression | CES-D | 102 | 95 | −0.32∗ | |||
| Lee et al. (2020) [ | Acupuncture | WLC | Depression | HADS-D | 49 | 49 | −2.66∗∗∗ |
| Anxiety | HADS-A | 49 | 49 | −0.91∗∗∗ | |||
| Lichstein et al. (2013) [ | CBTi | Hypnotic taper | Anxiety | STAI | 22 | 18 | −0.35 |
| Depression | GDS | 22 | 18 | −0.72∗ | |||
| Martinez et al. (2014) [ | CBTi | Sleep hygiene | Anxiety | SCL-90-R | 27 | 20 | −0.06 |
| Depression | SCL-90-R | 27 | 20 | −0.37 | |||
| McCrae et al. (2019) [ | CBTi | WLC | Anxiety | STAI | 24 | 23 | −0.42 |
| Depression | BDI | 24 | 23 | −0.57 | |||
| McCurry et al. (1998) [ | CBTi | WLC | Depression | CES-D | 20 | 9 | −0.08 |
| Nguyen et al. (2017) [ | CBTi | TaU | Anxiety | HADS-A | 13 | 11 | −0.98∗ |
| Depression | HADS-D | 13 | 11 | −1.73∗∗∗ | |||
| Nguyen et al. (2019) [ | CBTi | TaU | Anxiety | HADS-A | 9 | 6 | −0.37 |
| Depression | HADS-D | 9 | 6 | −1.51∗ | |||
| Norell-Clarke et al. (2015) [ | CBTi | Relaxation + sleep hygiene | Depression | BDI | 24 | 20 | −0.33 |
| Park et al. (2015) [ | Nordic walking | General walking | Depression | BDI | 12 | 12 | −1.10∗ |
| Peoples et al. (2019) [ | CBTi | Sleep hygiene + Armodafinil + placebo | Depression | PHQ-9 | 30 | 30 | −0.97∗∗∗ |
| Raskind et al. (2013) [ | Prazosin | Placebo | Depression | HAM-D | 32 | 35 | −0.67∗∗ |
| Depression | PHQ-9 | 32 | 35 | −0.69∗∗ | |||
| PTSD | CAPS | 32 | 35 | −0.83∗∗ | |||
| Sadler et al. (2018) [ | CBTi | Sleep education | Anxiety | GAI | 22 | 21 | −2.02∗∗∗ |
| Depression | GDS | 22 | 21 | −4.14∗∗∗ | |||
| Sato et al. (2019) [ | CBTi | TaU | Anxiety | HADS-A | 11 | 11 | −0.81 |
| Depression | CES-D | 11 | 11 | −1.52∗∗ | |||
| Savard et al. (2005) [ | CBTi | WLC | Anxiety | HADS-A | 27 | 30 | 0.35 |
| Depression | HADS-D | 27 | 30 | 0.27 | |||
| Schiller et al. (2018) [ | CBTi | WLC | Burnout | SMBQ | 25 | 26 | −0.03 |
| Sheaves et al. (2017) [ | CBTi | TaU | Suicidal ideation | BSS | 20 | 20 | −0.14 |
| Psychosis | PANSS pos | 20 | 20 | −0.31 | |||
| Psychosis | PANSS neg | 20 | 20 | −0.51 | |||
| Psychosis | PANSS tot | 20 | 20 | −0.34 | |||
| Sheaves et al. (2019) [ | CBT for nightmares | TaU | Anxiety | DASS-A | 11 | 9 | −0.65 |
| Depression | DASS-D | 11 | 9 | 0.15 | |||
| Dissociation | DES-B | 11 | 9 | −0.73 | |||
| Hallucinations | CAPS | 11 | 9 | −0.10 | |||
| Paranoia | GPTS | 11 | 9 | −0.82 | |||
| Psychosis | DES-B | 11 | 9 | −0.73 | |||
| Stress | DASS-S | 11 | 9 | −0.46 | |||
| Suicidal ideation | BSS | 11 | 9 | 0.48 | |||
| Song et al. (2020) [ | CBTi | Sleep hygiene | Depression | BDI | 12 | 13 | −0.07 |
| Anxiety | BAI | 12 | 13 | −0.98∗ | |||
| Tek et al. (2014) [ | Eszopiclone | Placebo | Depression | CDS | 19 | 17 | −0.07 |
| Psychosis | PANSS-pos | 19 | 17 | −0.32 | |||
| Psychosis | PANSS-neg | 19 | 17 | −0.05 | |||
| Psychosis | PANSS-tot | 19 | 17 | −0.10 | |||
| Thiart et al. (2015) [ | CBTi | WLC | Rumination | PSWQ | 59 | 54 | −0.84∗∗∗ |
| Wagley (2010) [ | CBTi | WLC | Depression | PHQ-9 | 24 | 10 | −1.55∗∗∗ |
| Wen et al. (2018) [ | Augmented acupuncture | Standard acupuncture | Depression | HADS-D | 43 | 46 | −1.01∗∗∗ |
| Yeung et al. (2011)a [ | Electroacupuncture | Placebo acupuncture | Depression | HDRS | 22 | 11 | −0.28 |
| Yeung et al. (2011)b [ | Standard acupuncture | Placebo acupuncture | Depression | HDRS | 23 | 12 | −0.47 |
| Zhang et al. (2020) [ | Acupuncture | Sham acupuncture | Depression | SDS | 46 | 44 | −3.56∗∗∗ |
| Anxiety | SAS | 46 | 44 | −3.93∗∗∗ | |||
| Zhu et al. (2018) [ | Tai Chi | TaU | Depression | SDS | 37 | 12 | −0.30 |
Note: ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001. CBTi = cognitive behavioural therapy for insomnia, dx = diagnosis, IRT = image rehearsal therapy, MH = mental health, ne = number of participants in intervention group, nc = number of participants in the control group, PTSD = post-traumatic stress disorder, TaU = treatment as usual, WLC = wait list control. abSubscript indicates that the study reports multiple eligible interventions in the same study, in these situations both interventions were included as separate studies in the analysis and the control was halved accordingly.
Fig. 1PRISMA diagram showing the flow of studies through the review.
The effect of improving sleep on mental health outcomes.
| Outcome | 95% CI | |||||
|---|---|---|---|---|---|---|
| Composite outcomes | −0.53∗∗∗ | −0.69 to −0.38 | 76% | 291.94∗∗∗ | 72 | 8608 |
| Depression | −0.63∗∗∗ | −0.84 to −0.43 | 81% | 322.03∗∗∗ | 61 | 7868 |
| Anxiety | −0.51∗∗∗ | −0.77 to −0.24 | 82% | 186.92∗∗∗ | 35 | 5819 |
| Stress | −0.42∗ | −0.79 to −0.05 | 55% | 11.05 | 6 | 419 |
| Psychosis spectrum | ||||||
| PANSS total | −0.17 | −0.53 to 0.19 | 0% | 0.41 | 3 | 121 |
| Positive symptoms | −0.26∗ | −0.43 to −0.08 | 0% | 1.71 | 5 | 1715 |
| Negative symptoms | −0.28 | −3.22 to 2.65 | 0% | 1.00 | 2 | 76 |
| Suicidal ideation | 0.10 | −3.74 to 3.94 | 20% | 1.25 | 2 | 60 |
| PTSD | −0.72 | −2.90 to 1.46 | 0% | 0.59 | 2 | 91 |
| Rumination | −0.49∗ | −0.93 to −0.04 | 36% | 4.65 | 4 | 355 |
| Burnout | −0.03 | −0.58 to 0.52 | – | – | 1 | 51 |
Notes: ∗∗∗p < 0.001, ∗p < 0.05, PANSS = Positive and Negative Symptoms Scale, PTSD = Post Traumatic Stress Disorder.
Fig. 2Forest plot showing the effect of improving sleep on composite mental health outcomes.
Fig. 3Forest plot showing the effect of improving sleep on depression.
Fig. 4Forest plot showing the effect of improving sleep on anxiety.
Fig. 5Forest Plot Showing the Effect of Improving Sleep on Stress, Suicidal Ideation, PTSD, and rumination.
Fig. 6Forest plot showing the effect of improving sleep on psychosis spectrum outcomes.
Categorical moderators of the effect of improving sleep on composite mental health outcomes.
| Variable | Levels | 95% CI | |||
|---|---|---|---|---|---|
| Significant effect on sleep | Yes | 72 | −0.53 | −0.69 to −0.38 | 17.69∗∗∗ |
| No | 31 | −0.12 | −0.24 to 0.01 | ||
| Clinical status of MH | Clinical | 15 | −0.72 | −1.14 to −0.30 | 0.92 |
| Non-clinical | 45 | −0.50 | −0.68 to −0.31 | ||
| Comorbidities | Mental health | 18 | −0.64 | −1.00 to −0.29 | 0.63 |
| Physical health | 20 | −0.54 | −0.76 to −0.32 | ||
| No comorbidities | 31 | −0.47 | −0.72 to −0.23 | ||
| Follow-up point | Short (<6 months) | 61 | −0.60 | −0.77 to −0.42 | 10.75∗∗ |
| Long (≥6 months) | 11 | −0.18 | −0.36 to −0.00 | ||
| Assessment type | Self-reported | 66 | −0.54 | −0.70 to −0.38 | 0.62 |
| Clinician rated | 6 | −0.44 | −0.65 to −0.23 | ||
| Adjusted data | Adjusted | 21 | −0.51 | −0.77 to −0.26 | 0.01 |
| Unadjusted | 51 | −0.53 | −0.72 to −0.35 | ||
| Recruitment setting | Clinical (MH) | 12 | −0.52 | −1.00 to −0.04 | 3.72 |
| Clinical (PH) | 14 | −0.52 | −0.76 to −0.28 | ||
| Community | 39 | −0.39 | −0.53 to −0.26 | ||
| Mixed | 9 | −1.12 | −1.94 to −0.31 | ||
| Recruitment method | Voluntary | 49 | −0.46 | −0.58 to −0.34 | 0.98 |
| Health professional | 7 | −0.65 | −1.45 to 0.14 | ||
| Mixed | 8 | −0.88 | −1.80 to 0.04 | ||
| Control group | Active control | 34 | −0.58 | −0.87 to −0.30 | 0.57 |
| TaU | 13 | −0.52 | −0.75 to −0.29 | ||
| Wait-list | 25 | −0.46 | −0.63 to −0.29 | ||
| Risk of bias | High | 31 | −0.38 | −0.56 to −0.21 | 0.74 |
| Low | 10 | −0.55 | −0.91 to −0.20 | ||
| Intervention type | Acupuncture | 7 | −1.17 | −2.08 to −0.25 | 2.46 |
| CBTi | 53 | −0.44 | −0.59 to −0.29 | ||
| Exercised based | 4 | −0.52 | −0.85 to −0.19 | ||
| Pharmacological | 2 | – | – | ||
| Sleep hygiene only | 2 | – | – | ||
| Sleep restriction only | 1 | – | – | ||
| CBT for nightmares | 1 | – | – | ||
| Herbal tea | 1 | – | – | ||
| Intervention format | Group | 11 | −0.42 | −0.92 to 0.08 | 0.25 |
| Individual | 52 | −0.55 | −0.73 to −0.38 | ||
| Intervention delivery | Clinician delivered | 43 | −0.63 | −0.87 to −0.38 | 4.50∗ |
| Self-administered | 23 | −0.34 | −0.43 to −0.26 | ||
| Country of origin | Australia | 5 | −1.50 | −2.39 to −0.60 | 53.69∗∗∗ |
| Canada | 4 | −0.12 | −0.40 to 0.17 | ||
| China | 8 | −0.85 | −1.59 to −0.11 | ||
| Germany | 3 | −0.49 | −0.90 to −0.08 | ||
| Korea | 4 | −0.78 | −1.70 to 0.15 | ||
| Netherlands | 3 | −0.16 | −0.29 to −0.03 | ||
| Sweden | 8 | −0.28 | −0.53 to −0.03 | ||
| Taiwan | 4 | −0.57 | −0.61 to −0.52 | ||
| UK | 9 | −0.36 | −0.51 to −0.22 | ||
| USA | 20 | −0.50 | −0.71 to −0.28 | ||
| New Zealand | 2 | – | – | ||
| Spain | 1 | – | – |
Notes: CBTi = cognitive behavioural therapy for insomnia, MH = Mental Health, PH = Physical Health, TaU = treatment as usual, WLC = wait list control.
∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.
Studies in the ‘No’ moderator category were excluded from the review due to having no significant effect on sleep quality but were included for moderation analysis.
The ‘exercise based’ category combines separate interventions with exercise as a key element, including walking, yoga and Tai Chi.
Not included in subgroup analysis due to low number.
Continuous moderators of the effect of improving sleep on composite mental health outcomes.
| Variable | B | SE | 95% CI | |
|---|---|---|---|---|
| Publication year | 72 | −0.02 | 0.02 | −0.05 to 0.02 |
| Journal impact | 71 | 0.01 | 0.01 | −0.01 to 0.03 |
| Age | 71 | 0.00 | 0.01 | −0.01 to 0.02 |
| Sex | 71 | 0.00 | 0.00 | −0.00 to 0.01 |
| Sleep effect | 70 | 0.77∗∗∗ | 0.13 | 0.52 to 1.02 |
| Intervention duration | 70 | 0.02 | 0.02 | −0.03 to 0.06 |
| Contact time | 55 | 0.00 | 0.01 | −0.02 to 0.01 |
| Number of sessions | 61 | 0.00 | 0.01 | −0.02 to 0.01 |
Fig. 7Weighted risk of bias summary plot.
Fig. 8Contrast enhanced funnel plot for the effect of improving sleep on composite mental health (solid grey markers) with imputed studies (hollow markers).